Literature DB >> 8614539

Japanese triplets with cerebrotendinous xanthomatosis are homozygous for a mutant gene coding for the sterol 27-hydroxylase (Arg441Trp).

Y Nagai1, M Hirano, T Mori, Y Takakura, S Tamai, S Ueno.   

Abstract

We present the first case of triplets with cerebrotendinous xanthomatosis (CTX). A C-to-T base change identified in the genomic DNA and cDNA encoding the sterol 27-hydroxylase led to replacement of arginine by tryptophan at position 441 (Arg441Trp) in the triplets. The triplets were homozygous and their mother was heterozygous for this mutant gene. The triplets exhibited an identical phenotypic expression, which was different from that of a sporadic CTX case with the same mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8614539     DOI: 10.1212/wnl.46.2.571

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series.

Authors:  Dénes Zádori; László Szpisjak; László Madar; Viktória Evelin Varga; Bernadett Csányi; Krisztina Bencsik; István Balogh; Mariann Harangi; Éva Kereszty; László Vécsei; Péter Klivényi
Journal:  Neurol Sci       Date:  2016-11-25       Impact factor: 3.307

2.  Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism.

Authors:  N Wakamatsu; M Hayashi; H Kawai; H Kondo; Y Gotoda; Y Nishida; R Kondo; S Tsuji; T Matsumoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

3.  Differing clinical features between Japanese siblings with cerebrotendinous xanthomatosis with a novel compound heterozygous CYP27A1 mutation: a case report.

Authors:  Shingo Koyama; Yuma Okabe; Yuya Suzuki; Ryosuke Igari; Hiroyasu Sato; Chifumi Iseki; Kazuyo Tanji; Kyoko Suzuki; Yasuyuki Ohta
Journal:  BMC Neurol       Date:  2022-05-25       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.